KALA
KALA BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.17
−5.48%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-111.5%
Return on equity
-95.3%
Return on assets
-232.1%
Return on invested capital
0.00x
Asset turnover
-$19.9M
Cash from operations
$0.37
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026